All lobbying filings

THORN RUN PARTNERS

THORN RUN PARTNERS filed a Q1 termination report for PROFESSIONAL COMPOUNDING CENTERS OF AMERICA on April 17, 2025, reporting $30,000 in lobbying income.

Lobbying for PROFESSIONAL COMPOUNDING CENTERS OF AMERICA · Compounding Pharmacy Supplier/Provider

All filings by THORN RUN PARTNERS · Everything PROFESSIONAL COMPOUNDING CENTERS OF AMERICA has reported

Filing · LD-2 quarterly report Q1 termination

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Apr 17, 2025

Income

$30,000

What the client paid this registrant for the period.

Client based in

Texas

Representation ended

Feb 28, 2025

The registrant reported terminating its work for this client.

Official filing document

Lobbyists on this filing 2

JESSIE HOWE BRAIRTON

Previously held: Senior Legislative Asst/Legislative Asst, Rep. Lamar Smith; LC/Asst, Senate Special Aging Committee
GARY PALMQUIST

Previously held: Legislative Director: Rep. Dennis Cardoza, Rep. Bob Clement, Rep. Ken Bentsen

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 3

Health Issues

Issues related to drug supply chain and drug shortages. Issues related to bioidentical compounded hormones.

Pharmacy

Issues related to the Drug Quality and Security Act, Compounding Pharmacy, Reimbursement, and Patient Access, animal compounding, and H.R.167 - Patient Access to Urgent-Use Pharmacy Compounding Act of 2023. H.R.3810 - Drug Origin Transparency Act of 2023.

Medicare/Medicaid

Medicare Part D reimbursement of bulk substances.

Bills named in this filing 2

H.R. 167
Patient Access to Urgent-Use Pharmacy Compounding Act of 2023
H.R. 3810
Drug Origin Transparency Act of 2023

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.